Co-Authors
This is a "connection" page, showing publications co-authored by Daniel Stadlbauer and Fatima Amanat.
Connection Strength
1.235
-
Repeated cross-sectional sero-monitoring of SARS-CoV-2 in New York City. Nature. 2021 02; 590(7844):146-150.
Score: 0.228
-
Anti-SARS-CoV-2 spike antibodies are stable in convalescent plasma when stored at 4° Celsius for at least 6 weeks. Transfusion. 2020 10; 60(10):2457-2459.
Score: 0.226
-
SARS-CoV-2 Seroconversion in Humans: A Detailed Protocol for a Serological Assay, Antigen Production, and Test Setup. Curr Protoc Microbiol. 2020 06; 57(1):e100.
Score: 0.221
-
A serological assay to detect SARS-CoV-2 seroconversion in humans. Nat Med. 2020 07; 26(7):1033-1036.
Score: 0.220
-
Differential T-Cell Reactivity to Endemic Coronaviruses and SARS-CoV-2 in Community and Health Care Workers. J Infect Dis. 2021 07 02; 224(1):70-80.
Score: 0.060
-
Immunological imprinting of the antibody response in COVID-19 patients. Nat Commun. 2021 06 18; 12(1):3781.
Score: 0.059
-
Robust neutralizing antibodies to SARS-CoV-2 infection persist for months. Science. 2020 12 04; 370(6521):1227-1230.
Score: 0.057
-
Convalescent plasma treatment of severe COVID-19: a propensity score-matched control study. Nat Med. 2020 11; 26(11):1708-1713.
Score: 0.056
-
Pre-existing Antineuraminidase Antibodies Are Associated With Shortened Duration of Influenza A(H1N1)pdm Virus Shedding and Illness in Naturally Infected Adults. Clin Infect Dis. 2020 05 23; 70(11):2290-2297.
Score: 0.055
-
Novel correlates of protection against pandemic H1N1 influenza A virus infection. Nat Med. 2019 06; 25(6):962-967.
Score: 0.052